Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes.
Soohyun Choe1,2, Woori Kwak1,2, Ehyun Kim1
1Department of Medical and Biological Sciences, The Catholic University of Korea, 14662 Bucheon, Republic of Korea.
Frontiers in Bioscience (Landmark Edition)
|April 29, 2024
Summary
Metabolism-related genes (MRGs) in pancreatic cancer influence immune responses and tumor growth. Identifying these genes could improve immunotherapy and overcome treatment resistance in this lethal disease.
Area of Science:
- Oncology
- Immunology
- Metabolic pathways
Background:
- Pancreatic ductal adenocarcinoma is a lethal cancer with limited treatment options.
- Altered cellular metabolism is a hallmark of cancer, impacting the tumor microenvironment (TME).
- Metabolic reprogramming in cancer cells affects immune cell function within the TME, promoting immunosuppression.
Purpose of the Study:
- To review the characteristics of metabolism-related genes (MRGs) in pancreatic cancer.
- To explore the link between metabolic gene signatures and immune reactions in pancreatic cancer.
- To identify potential therapeutic targets for enhancing immunotherapy.
Main Methods:
- Literature review of studies on pancreatic cancer metabolism and immunology.
- Analysis of metabolic pathways altered in pancreatic cancer.
- Examination of the role of MRGs in immune cell function within the TME.
Main Results:
- Metabolic reprogramming, including glucose, amino acid, and lipid metabolism, supports tumor growth and the TME.
- Tumor-infiltrating immune cells adapt their metabolism to create an immunosuppressive environment.
- Specific MRGs are associated with immune responses in pancreatic cancer.
Conclusions:
- MRGs play a critical role in pancreatic cancer progression and immune evasion.
- Targeting MRGs may offer novel strategies to enhance immunotherapy efficacy.
- Further research into MRGs could lead to improved treatment approaches for pancreatic cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K